U.S. Hospitals Are Running Out Of A Crucial Covid Drug Amid Delta Surge And Worldwide Shortages
Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Policy /policy Manufacturing /manufacturing Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news
More News: Actemra | Coronavirus | COVID-19 | Hospitals | International Medicine & Public Health | Pharmaceuticals | WHO